Amsel Medical

Amsel Medical is a private, pre-revenue medical device innovator focused on a novel vessel occlusion technology. Its flagship product, the SCureClamp iDOT, is a permanent, non-thermal, non-chemical clip delivered via an 18-gauge needle, designed to provide secure, transfixing occlusion superior to traditional ligation clips. With regulatory clearances in hand, the company is advancing towards commercialization in vascular surgery and trauma care, supported by a prestigious DoD SBIR grant for military applications. The technology addresses significant unmet needs in venous disease treatment and battlefield hemorrhage control.

Interdigitation Occlusion Technology (iDOT™) – a mechanical, permanent, non-thermal, non-chemical vessel occlusion platform delivered via an 18-gauge needle for secure, transfixing ligation similar to a suture.

In vascular occlusion, Amsel competes against large medtech companies offering thermal ablation (RF, laser), sclerotherapy, and mechanical clips (e.g., Medtronic, BD, Abbott). In trauma, it would compete against advanced hemostatic agents and tourniquet systems. Its key differentiation is the secure, transfixing, permanent mechanical occlusion via a minimally invasive needle, a unique combination in the market.